The Affordable Care Act One Year Later: Lessons for Addiction Medicine
Of the estimated 18 million adults potentially eligible for Medicaid in all 50 states, at least 2.5 million have substance use disorders. Of the 19 million uninsured adults with slightly higher incomes who are eligible for subsidized exchange insurance, an estimated 2.8 million struggle with substance abuse, according to the most recent national survey by the U.S. Substance Abuse and Mental Health Services Administration. In California, 10,568 newly enrolled beneficiaries had signed up for addiction services by May, an increase of more than 30 percent under the state Medicaid program. The number of adults in Washington state’s Medicaid treatment facilities doubled in the first six months of the year. Vermont Medicaid officials also said they saw a substantial increase in the number of Medicaid enrollees seeking treatment.
This lecture will review the latest policy developments relating to substance abuse treatment under the affordable care act including integration of care, quality measures, insurance coverage for substance abuse treatment. Issues specific to safety net populations and private insurers will be discussed.
PRICE/PURCHASE -- $100
You must sign in or register register on this site before purchasing using the link on the upper right corner of this page. Only after registering will you see the "Add to Cart" button. To purchase, scroll to the bottom of the page and click "Add to Cart."
PHYSICIANS: The California Society of Addiction Medicine (CSAM) is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of 1.5 AMA PRA Category 1 Credit™ Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Maintenance of Certification (MOC) Program can apply a maximum of 1.5 AMA/PRA Category 1 Credits™ for completing the Review Course.
Continuing education credit is also available for nurses, psychologists, pharmacists, physician assistants, therapists, and drug abuse counselors.
- Addiction medicine specialists who want an overview of the latest developments in the field and their relevance to clinical practice
- Primary care clinicians who want to get a better understanding of addiction and manage patients with addictions in their practice
- Public health officials who want an understanding of the current state of addiction treatment
- Non-physicians who are involved in the treatment of addiction
- Understand the provisions of the Affordable Care Act as applies to substance abuse treatment providers and patients.
- Understand anc comply with the ACA in relationship to integration of care, quality measures.
- Address requirements of the ACA for private insurance and safety net populations.
- H. Westley Clark, MD, JD, MPH, Dean's Executive Professor, Public Health Program, Santa Clara University
- Judith Martin, MD, Medical Director of Substance Abuse Services, Dept. of Public Health, City & County of San Francisco
- David Pating, MD, Chief of Addiction Medicine at Kaiser Medical Center, San Francisco
None of the above have relevant financial relationships to disclose.
|Sharone Abramowitz, MD||No relevant financial Relationship to disclose|
|Anthony Albanese, MD, FASAM||No relevant financial Relationship to disclose|
|Chwen-Yuen (Angie) Chen, MD||No relevant financial Relationship to disclose|
|Helen Py Driscoll, MD||No relevant financial Relationship to disclose|
|Murtuza Ghadiali, MD||No relevant financial Relationship to disclose|
|Anna Lembke, MD||No relevant financial Relationship to disclose|
|Claudia Landau, MD||No relevant financial Relationship to disclose|
|Jean Marsters, MD||No relevant financial Relationship to disclose|
|Thomas Meeks, MD||No relevant financial Relationship to disclose|
|Ingeborg Schafhalter-Zoppoth, MD||No relevant financial Relationship to disclose|
- 1.50 AMA Category 1